Dong Hong Chen

Dong Hong Chen

Plus aucun poste en cours
55 ans
Consumer Services
Health Technology
Distribution Services

Profil

Dong Hong Chen worked as a Senior Scientist at GlaxoSmithKline (China) R&D Co., Ltd. from 2010 to 2013.
From 2013 to 2014, served as Medical Director-Asia Pacific Region at STAAR Surgical Co. Between 2015 and 2016, was Deputy General Manager-Research & Development at Vanway Pharmaceutical Holdings Ltd. From 2016 to 2019, held the position of Head-Clinical Development & Medical Affairs at Alcon Hong Kong Ltd. Also worked as Chief Medical Officer at Ocumension Therapeutics.
Education includes a doctorate from Fudan University conferred in 2003, a graduate degree from Nanjing Medical University conferred in 1997, and an undergraduate degree from Yangzhou University conferred in 1991.

Anciens postes connus de Dong Hong Chen

SociétésPosteFin
Corporate Officer/Principal 01/10/2019
Directeur Technique/Scientifique/R&D 01/04/2016
STAAR SURGICAL COMPANY Directeur Technique/Scientifique/R&D 01/12/2014
GlaxoSmithKline (China) R&D Co., Ltd.
Corporate Officer/Principal 01/01/2013
OCUMENSION THERAPEUTICS Directeur Technique/Scientifique/R&D -
Voir l'expérience en détail de Dong Hong Chen

Formation de Dong Hong Chen

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

88

Relations au 1er degré

8

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées8

Health Technology

Consumer Services

Consumer Services

Distribution Services

Consumer Services

Health Services

GlaxoSmithKline (China) R&D Co., Ltd.

Commercial Services

  1. Bourse
  2. Insiders
  3. Dong Hong Chen
🔇